| 11.03.2025 12:41 | INDV | Director/PDMR Shareholding | RNS |
| 11.03.2025 10:18 | INDV | Director/PDMR Shareholding | RNS |
| 10.03.2025 17:39 | INDV | Director/PDMR Shareholding | RNS |
| 05.03.2025 14:02 | INDV | Director/PDMR Shareholding | RNS |
| 04.03.2025 13:45 | INDV | Holding(s) in Company | RNS |
| 04.03.2025 13:35 | INDV | Indivior shrinks size of board after US primary listing | Alliance |
| 04.03.2025 11:23 | INDV | Director/PDMR Shareholding | RNS |
| 04.03.2025 11:23 | INDV | Holding(s) in Company | RNS |
| 04.03.2025 07:00 | INDV | Further Changes to Board of Directors | RNS |
| 04.03.2025 07:00 | INDV | Indivior PLC Files 2024 Annual Report on Form 10-K | RNS |
| 03.03.2025 09:29 | INDV | Total Voting Rights | RNS |
| 28.02.2025 14:06 | INDV | IN BRIEF: Incoming Indivior CEO Ciaffoni, other directors buy shares | Alliance |
| 28.02.2025 09:43 | INDV | Director/PDMR Shareholding | RNS |
| 28.02.2025 09:42 | INDV | Director/PDMR Shareholding | RNS |
| 28.02.2025 07:00 | INDV | Holding(s) in Company | RNS |
| 27.02.2025 16:31 | INDV | Director/PDMR Shareholding | RNS |
| 27.02.2025 16:29 | INDV | Director/PDMR Shareholding | RNS |
| 27.02.2025 14:46 | INDV | IN BRIEF: Indivior names former Collegium Pharmaceutical chief as CEO | Alliance |
| 27.02.2025 07:00 | INDV | Joseph Ciaffoni Appointed Chief Executive Officer | RNS |
| 25.02.2025 09:45 | INDV, ZEG, MAB1 | LONDON BROKER RATINGS: Morgan Stanley raises B&M but Goldman cuts | Alliance |
| 25.02.2025 07:00 | INDV | Holding(s) in Company | RNS |
| 24.02.2025 10:50 | INDV | Indivior gets US FDA nod for faster Sublocade opioid treatment start | Alliance |
| 24.02.2025 07:00 | INDV | FDA Approval of SUBLOCADE Label Changes | RNS |
| 20.02.2025 13:24 | INDV | Indivior shares drop on 2025 revenue decline forecast | Alliance |
| 20.02.2025 07:00 | INDV | Final Results | RNS |
| 13.02.2025 14:04 | SAFE, INDV, LLOY | UK earnings, trading statements calendar - next 7 days | Alliance |
| 12.02.2025 09:18 | INDV | IN BRIEF: Indivior faces FDA delay on Sublocade label change | Alliance |
| 12.02.2025 07:00 | INDV | Delayed FDA Approval of SUBLOCADE Label Changes | RNS |
| 04.02.2025 15:12 | INDV | Notice of Results | RNS |
| 04.02.2025 10:41 | AZN, GSK, INDV | IN BRIEF: Indivior completes USD100 million share buyback | Alliance |
| 04.02.2025 07:00 | INDV | Completion of Share Repurchase Program | RNS |
| 04.02.2025 07:00 | INDV | Transaction in Own Shares | RNS |
| 03.02.2025 09:26 | INDV | Total Voting Rights | RNS |
| 03.02.2025 07:00 | INDV | Appointment of Independent Non-Executive Director | RNS |
| 28.01.2025 15:30 | INDV | Dr. David Wheadon appointed Chair of the Board | RNS |
| 28.01.2025 09:43 | INDV | Holding(s) in Company | RNS |
| 28.01.2025 07:00 | INDV | Transaction in Own Shares | RNS |
| 27.01.2025 09:08 | INDV | Holding(s) in Company | RNS |
| 21.01.2025 07:00 | INDV | Transaction in Own Shares | RNS |
| 16.01.2025 16:00 | INDV | Replacement Transaction in Own Shares | RNS |
| 14.01.2025 07:00 | INDV | Transaction in Own Shares | RNS |
| 09.01.2025 13:00 | INDV | Indivior Provides Historical Financials in US GAAP | RNS |
| 07.01.2025 08:55 | INDV | Holding(s) in Company | RNS |
| 07.01.2025 07:00 | INDV | Transaction in Own Shares | RNS |
| 03.01.2025 09:28 | INDV, WISE, VTY | LONDON BROKER RATINGS: Indivior and Vistry price targets cut | Alliance |
| 02.01.2025 09:31 | INDV | Total Voting Rights | RNS |
| 31.12.2024 09:53 | INDV | Holding(s) in Company | RNS |
| 31.12.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 24.12.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 23.12.2024 10:32 | INDV | Director/PDMR Shareholding | RNS |
| 03.12.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 02.12.2024 09:44 | INDV | Total Voting Rights | RNS |
| 26.11.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 22.11.2024 07:00 | INDV | Indivior to Participate in Upcoming Investor Event | RNS |
| 15.11.2024 07:00 | INDV | Director Declaration | RNS |
| 12.11.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 11.11.2024 14:29 | INDV | Holding(s) in Company | RNS |
| 08.11.2024 16:50 | INDV | Block listing Interim Review | RNS |
| 08.11.2024 09:55 | INDV | Indivior to talk with Oaktree after accusations of "value destruction" | Alliance |
| 08.11.2024 07:00 | INDV | Indivior Responds to Letter from Oaktree | RNS |
| 05.11.2024 11:19 | INDV | Indivior completes refinancing of secured term loan | Alliance |
| 05.11.2024 07:00 | INDV | Indivior Completes Refinance of Secured Term Loan | RNS |
| 05.11.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 01.11.2024 11:59 | INDV | Total Voting Rights | RNS |
| 29.10.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 24.10.2024 14:37 | INDV | Indivior shares jump as backs guidance despite stiff competition | Alliance |
| 24.10.2024 07:00 | INDV | 3rd Quarter Results | RNS |
| 22.10.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 17.10.2024 15:48 | THRU, ULVR, WPS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 15.10.2024 07:00 | INDV | Notice of Results | RNS |
| 15.10.2024 07:00 | INDV | Transaction in Own Shares | RNS |
| 11.10.2024 09:36 | ASC, INDV, LIO | LONDON BROKER RATINGS: JPMorgan cuts Vistry; Goldman lowers Ceres | Alliance |
| 10.10.2024 19:30 | INDV | TOP NEWS: Shares in Indivior plunge 19% as profit warning | Alliance |
| 10.10.2024 12:00 | INDV | Preliminary Q3 Results & Updated FY 2024 Guidance | RNS |
| 08.10.2024 07:00 | INDV | Transaction in Own Shares | RNS |
